CAMK2G and diabetes mellitus: Indeed, the increased O-GlcNAcylation of CaMKII and subsequent phosphorylation of RyR2 is already established to drive arrhythmias in diabetes, suggesting that prevention of CaMKII O-GlcNAcylation may be a therapeutic strategy [13].